Mr Sergio Pagliarini 03210752

Macula Care Ltd


  • Not Fee assured
  • Cataract Full Pathway provider

    I offer Bupa customers standard cataract surgery on the Full Pathway package option at Edgbaston Eye Consultants .

    This package includes your appointments before and after surgery, as well as your surgery and mono-focal lenses. It means you won’t use up your out-patient benefit or receive any additional bills from your surgeon (or anaesthetist, if you need one) for eligible treatment.

    Please call the Bupa Eye Care team to find out more about and to pre-authorise your treatment on 0345 600 7267.


Specialises in

  • Medical
  • Surgical


  • Video and telephone consultations

About me

I am a Consultant Ophthalmic Surgeon at University Hospital of Coventry. Previously, I was a Consultant at the Queen's Medical Centre, Nottingham.

I graduated and obtained my specialist certificate in Italy. I then spent two years of clinical and research fellowships in Medical Retina at Moorfields Eye Hospital in London and at St. Thomas’s Hospital where I conducted laboratory based basic science research on age-related macular degeneration (AMD). Thereafter, I continued doing research and clinical work at the University of Rome. I then returned to the UK where I established my career. Prior to taking my first NHS consultant post in 2000, I visited several American Universities where I consolidated my retinal specialist knowledge.

I practice general ophthalmology and carry out micro-incision cataract surgery (≤2.2 mm incision).

My main sub-specialty is medical retina with emphasis on age-related macular degeneration, retinal vein occlusions and diabetic retinopathy (AMD).

I developed the NHS and private sector services in Coventry and Warwickshire for photodynamic therapy (PDT) for wet AMD. Although replaced by anti-VEGF, PDT is still a useful treatment in certain sub-types of wet AMD poorly responsive to injection treatments and in central serous retinopathy. I developed anti-VEGF and intravitreal drug delivery services for a variety of macular diseases ranging from wet-AMD to retinal vein occlusions, diabetic macular oedema, vitreomacular traction and macular holes.

I have led both NHS and private sectors go develop state-of-the-art diagnostic services based on OCT and multi-modality retinal imaging, that greatly increase the accuracy of clinical decisions on when to patients with macular diseases requiring repeat intravitreal injections. The design and opening of the Macular Unit at the Hospital of St. Cross in Rugby is the achievement of which I am proud of, as it has inspired colleagues from other units.

At the Warwickshire Nuffield Hospital I provide Multimodality diagnostic imaging ranging from OCT to Fluorescein angiography, ICG angiography and fundus autofluorescence, to support treatment decisions and management of macular diseases.

I am experienced with any of the injection treatments of macular diseases, such as Lucentis, Eylea, Avastin and Jetrea.

I offer my patients the benefit of easy access and expertise to high-tech retinal imaging and scanners, such as optical coherence tomography (OCT), OCTA (OCT Angiography), fluorescein adn ICG angiography. These are essential best practice tools for contemporary and effective management of macular diseases.

Areas of interest

Retinal diseases. Age related macular degeneration (AMD); Cataract surgery; Macular diseases; Photodynamic therapy (PDT); Retinal vein occlusions; Diabetic retinopathy

Medical secretaries

About me
My outcomes
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.